News Articles and Montana BioScience Alliance Newsletters
Their ideas included a virtual reality textbook, a new building material, a food incubator, a device to assist construction workers, various software solutions and a student-focused professional networking platform.
As research programs grow at the University of Montana, a team of vaccine scientists are making headway into long-term COVID-19 prevention and clinical trials for an opioid vaccine.
The Montana BioScience Alliance is pleased to announce that Michelle Hood has been inducted into the 2021 MBA Hall of Fame. Ms. Hood is Executive Vice President and Chief Operating Officer of the American Hospital Association and was instrumental in the formation of the Montana BioScience Alliance.
Soon, someone feeling the need for some extra Z’s may benefit from a wearable device that aids the brain in the biochemical cleansing that leaves a person feeling refreshed after a full night of sleep. As part of the first large-scale study on the effectiveness of the new technology, Montana State University researchers will analyze brain scans of participants who wear a prototype of the device, which works by applying precise electrical stimulation to the brain. The project, which involves multiple universities, […]
University of Montana first-year student Tori Matteson can’t point to a specific event that peaked her interest in becoming a pharmacist – there aren’t any in her family – but her curiosity about medicine started early in her high school years growing up in Butte. When it came time to enroll in college…she said it was “UM all the way.”
Drug makers have been racing at a breakneck pace to develop respiratory syncytial virus (RSV) vaccines this year. On May 3, the U.S. Food and Drug Administration (FDA) announced it has approved Arexvy, the first-ever RSV vaccine for individuals 60 and over.
Information on Small Business Funding Webinar, National Small Business Week, America’s SEED Fund Week — and more
SBIR and STTR grant funding opportunities offer small business entrepreneurs a chance to obtain non-dilutive funding for early-stage research and development. Applications are accepted three times a year. The next deadline is April 5. Omnibus Solicitations. Researcher-initiated ideas are proposed via the SBIR and STTR Omnibus grant solicitations. These FOAs do not specify a topic, though they link to identified topics of interest for each participating awarding component. Most small business applications to NIH are submitted to the Omnibus solicitations. Specific Funding […]
FDA advisers endorsed the safety and efficacy of GSK’s respiratory syncytial virus (RSV) vaccine in older adults, setting up a final mad dash with Pfizer as both companies eye the regulatory finish line with their promising new vaccines.
Researchers from Diaceutics and the Personalized Medicine Coalition has published a special report in JCO Precision Oncology that provides an in-depth look at United States health systems’ efforts to deploy potentially paradigm-shifting targeted and immuno-oncology drugs to improve care for lung cancer patients.
View the Spring 2023 Newsletter now!
View the Winter 2022 Newsletter now!